DUBLIN, Feb. 24, 2017 /PRNewswire/ -- Endo International plc (NASDAQ / TSX: ENDP) today announced that one of its operating companies, Endo Pharmaceuticals Inc. based in Malvern, Pennsylvania, is ...
A voluntary recall of the erectile dysfunction treatment, Edex (alprostadil for injection) was announced due to a defect in the crimp caps used in the manufacturing of the product lot. Endo announced ...
The company is voluntarily recalling one lot of Edex due to a lack of container closure integrity. Endo International plc announced on Feb. 24, 2017 that Endo Pharmaceuticals (Malvern, PA) was ...
This defect has the potential to lead to a loss of container closure integrity, which could impact the product's sterility assurance and may lead to serious adverse events such as infections, both ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback